Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
Rhea-AI Summary
Organogenesis Holdings (Nasdaq: ORGO), a regenerative medicine company specializing in Advanced Wound Care and Surgical & Sports Medicine markets, has announced its participation in two major healthcare investor conferences in September.
Management will present at the Cantor Fitzgerald Global Healthcare Conference on September 3 at 2:10 p.m. ET and the Morgan Stanley Global Healthcare Conference on September 10 at 2:35 p.m. ET. Both events will take place in New York City and feature fireside chat sessions that will be available via webcast on the company's investor relations website for approximately 30 days after the events.
Positive
- None.
Negative
- None.
News Market Reaction – ORGO
In the Aug 28 session, ORGO gained 5.79%, reflecting a notable positive market reaction. Argus tracked a peak move of +2.6% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences:
The Cantor Fitzgerald Global Healthcare Conference at the New York Marriott Marquis in New York, NY
- Management will participate in a fireside chat on Wednesday, September 3 at 2:10 p.m. Eastern Time.
The Morgan Stanley Global Healthcare Conference at the Sheraton Times Square in New York, NY
- Management will participate in a fireside chat on Wednesday, September 10 at 2:35 p.m. Eastern Time
Webcasts of the fireside chat sessions will be accessible by visiting the “News & Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. Archives of the webcasts will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com
Investor Inquiries: ICR Healthcare Mike Piccinino, CFA OrganoIR@ICRHealthcare.com Press and Media Inquiries: Organogenesis communications@organo.com